The making of a disease

This journalist authored commentary in the BMJ offers some perceptions into the driving factors in today's medicine. The topic example is a little uncomfortable, and is not the point for posting. Many conditions for which a specific drug treats, that a specific drug-maker markets, will have a similar scenerio.
http://bmj.com/cgi/content/full/326/7379/45

Summary points
Researchers with close ties to drug companies are defining and classifying a new medical disorder at company sponsored meetings
The corporate sponsored definitions of "female sexual dysfunction" are being criticised as misleading and potentially dangerous
Commonly cited prevalence estimates, which indicate that 43% of women have "female sexual dysfunction," are described as exaggerated and are being questioned by leading researchers
Controversy surrounds current attempts to medicalise sexual problems and establish "normative data" for a range of physiological measurements of female sexual response
The role of drug companies in the construction of new conditions, disorders, and diseases needs more public scrutiny